IACP’s Executive Vice President John Voliva, RPh, is extensively quoted in a Drug Topics article this week, NECC and the Future of Compounding Pharmacy.

“The FDA and Massachusetts Board of Pharmacy, according to Voliva and many other members of the media, “had clear authority to investigate and take action that would have stopped the operations at New England Compounding Center, and both had been informed of problems there. Neither did.”

“The NECC tragedy provided more evidence that an increase in the communication and coordination between the FDA and the State Boards of Pharmacy was vital,” said Voliva.

Read the entire article and more of Voliva’s comments here.